Yvette K. Stoliker
Wayland Baptist University
RSWR 3345.VC03
10 October 2012
Abstract
Nutrigenomics is the relationship between the nutrients that the body ingests and the cells within the body. Each cell has a unique purpose to maintain the bodies’ health. The medical profession should understand deficiency diseases of the body and be able to apply nutrient therapy through the application of nutrigenomics. Several reasons are affecting the acceptance in the medical profession. History has proven this application, but there are long term effects that need to be analyzed. A lack of nutrition education in the medical profession is one reason that nutrigenomics is not applied. There is significant research that needs to be performed on cell interaction, beyond the already identified deficiency diseases. Ethical, legal and social issues need to be considered when advancing the nutrigenomics research and medical profession applications.
Table of Contents Introduction 4 Nutrigenomics and the Medical Profession 4 What is Nutrigenomics? 5 Nutrigenetics vs. Nutrigenomics 5 An Example to Relate the Concept of Nutrigenomics 5 History and Applications 6 Historical 6 Recent Application 7 Current Medical Application 7 Reasons for the Lack of Medical Profession Application 8 Personalized Medicine Goal 8 Medical Profession Need for Knowledge to Apply Nutrigenomics 8 Nutrigenetic Testing for the Application of Nutrigenomics 9 Ethical Challenges 11 Legalities 13 Societal Issues 13 Conclusion 15 References 16
Reviewing Obstacles: Will the Medical Profession Begin to Apply Nutrigenomics?
A common expression of health, food and how it pertains to the body is, “You are what you eat”. Is this something that should be lived by on a daily basis or is it
References: Castle, D., & Ries, N. (2007). Ethcial, legal and social issues in nutrigenomics:The challenges of regulating service delivery and building health professional capacity. Science Direct. 138-143. doi:10.1016/j.mrfmmm.2007.03.017 Fenech, M. (2010). Nutriomes and nutrient arrays-the key to personalised nutrition for DNA damage prevention and concer growth control. Genome Integrity 2010, 1-11. doi:10.1186/2041-9414-1-11 Genius, S. (2008). Our genes are not our destiny: Incorporating molecular medicine into clinical paractice. Journal of Evaluation in Clinical Practice, 14(2). 94-102. Ghosh, D; Skinner, MA; Laing, WA. (2007). Pharmacogenomics and nutrigenomics: Synergies and differences. European Journal of Clinical Nutrtion, 61. 567-574. doi:10.1038/sj.ejcn.1602590 Harvey, A. (2009). From Genetic risk to post-genomic uncertainties:nutrigenomics and the birth of the "genetic entrepreneur". New Genetics and Society, 28. 119-137. doi:10.1080/14636770902901447 Hesketh, John; Wybranska,Iwona; Dommels, Yvonne; King, Maria; Elliot, Ruan; Pico, Catalina; Keijer, Jaap. (2006). Nutrient-gene interactions in benefit-risk analysis. British Journal of Nutrition, 95. 1232-1236. doi:10.1079/BJN20061749 Komduur, Rixt H.; Korthals, Michiel; te Molder, Hedwig. (2009). The good life: living for health and a life without risks? On a prominent script of nutrigenomics. British Journal of Nutrition, 101. 307-316. doi:10.1017/S000711450807114508076253 Ronteltap, A.; van Trijp, J.C.M.; Renes, R.J. (2009). Consumer acceptance of nutrigenomics-based personalised nutrition. British Journal of Nutrition, 101. 132-144. doi:10.1017/S0007114508992552 Saukko, P., Reed, M., Britten, N., & Hogarth, S. (2010). Negotiating the boundary between medicine and consumer cuolture: Online marketing of nutrigenetic tests. Science Direct. 744-753. doi:10.1016/j.socscimed.2009.10.066 Varker, Kimberly A., MD; Ansel, Adam; Aukerman, Glen, MD; Carson, William E. III, MD. (1012). Review of complementary and alternative medicine and selected nutraceuticals: Background for a pilot study on nutrigenomic intervention in patientts with advanced cancer. Alternative Therapies, 18(2). 26-32.